Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1158)	12/20/1997 2:53:00 AM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

Zonagen lie #4: Why would anyone accuse a fine, upstanding corporate citizen like Zonagen of trying to mislead investors? I mean, take a look at this straightforward and honest press release: pslgroup.com I draw the reader's attention to the first paragraph: ---------------------- THE WOODLANDS, Texas, June 24, 1996 -- Zonagen, Inc. (NASDAQ:ZONA, Pacific ZNG) announced today that it has received notification from the United States Patent and Trademark Office that the patent covering the use of VASOMAX(TM) as a treatment for erectile dysfunction (impotency) has been allowed... ----------------------- Oh...and just for grins, Joe Podolski weighs in with a cautious projection for the NDA filing date: --------------------- .....We believe that we will be able to submit our VASOMAX(TM) NDA to the FDA in June of 1997." ------------------------- Message 2985680